Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine [Yahoo! Finance]
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Dynavax Announces $100 Million Accelerated Share Repurchase Program
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... [Yahoo! Finance]